As Nelson Mandela says, “Education is the most powerful weapon which you can use to change the world.” Education is the key to eliminating gender inequality, to reducing poverty, to creating a sustainable planet, to preventing needless deaths and illness, and to fostering peace.

The UN Global Compact has shared a special appeal for a corporate response to the COVID-19 pandemic: for all companies to take collective action to stem the outbreak through implementing our Ten Principles in the areas of human rights, labour, environment and anti-corruption.

The COVID-19 crisis makes one thing abundantly clear: the social contract between government, business, employees, and people is not working as it should. What steps can businesses take to remake the social contract and build for a better future?

COVID-19 has been declared a pandemic by the World Health Organization (WHO), with over 250,000 infected across the globe. UNDP will support countries to set up a multisectoral whole-of-society approach to face the challenges beyond the health sector

Looking for some good news as we enter yet another week of sheltering-in-place? Perhaps you feel like doing a Google search to discover an upside to the slow down?

Earlier in March, we announced that the Ceres 2020 in New York in-person event was cancelled due to the coronavirus pandemic. Since then, we’ve been working hard to reimagine how we can deliver the content we planned that aims to address the challenges investors, companies and policymakers alike face when it comes to sustainability.

On March 15, as COVID-19 cases in Los Angeles County began to mount, Southern California Edison learned that the Sheraton Fairplex Hotel & Conference Center at the LA County Fairgrounds in Pomona was under consideration as a possible quarantine site.

Unprecedented is a word we hear every day as the pandemic continues to evolve. At this time of stress and uncertainty, many are looking to the government for help, but I firmly believe that businesses also have to rise to the occasion.

When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals.

Our newly established testing laboratory in Berlin which supports the fight against the Corona virus is already running: In the lab, our employees – more than 140 have volunteered – are able to conduct up to 1,000 additional SARS-CoV-2 tests per day.